Note: The full article and accompanying features are only available whilst being signed in.
Summary
In today’s environment, Pharmaceutical companies find themselves in a bind. Until recently, if drugs made over $500 Million in annual revenue within three to five years of launch, they were considered hugely successful. They were a support to an extensive company portfolio and a component of greater company profit.
However, things have changed. The standards for a successful drug have become much higher and much more dangerous. Everyone is searching for the new product that posts incredible sales from the moment it’s on the market, and if they don’t find it, trouble may be on the horizon.
In this report, we examine the concept and components of effective pre-launch planning. We analyze the environment for Pharmaceuticals today in efforts to understand why launch is increasingly important. We describe the phases of pre-launch planning. We look at key organizational strategies, marketing tactics, regulatory considerations, and even global issues.
Finally, to help companies make tough decisions and engage in effective planning, we examine powerful pre-launch analytics techniques and case studies of success.
To purchase this report, please visit:
> Pre-Launch Planning
Want more?
The content of this page been summarized. To view the full content, please register or sign in to the Eularis web site.
Register with Eularis
or
Sign in